CLDX

26.77

2.80% -0.77

Handel nachbörslich: 26.77

Celldex Therapeutics Inc (CLDX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$27.54

Offen:

$27.62

24-Stunden-Volumen:

1.21M

Relative Volume:

1.01

Marktkapitalisierung:

$1.78B

Einnahmen:

$5.79M

Nettoeinkommen (Verlust:

$-199.61M

KGV:

-8.8937

EPS:

-3.01

Netto-Cashflow:

$-188.48M

1W Leistung:

+1.36%

1M Leistung:

+7.25%

6M Leistung:

+67.94%

1J Leistung:

-9.80%

1-Tages-Spanne:

$26.31

$27.73

1-Wochen-Bereich:

$25.81

$27.98

52-Wochen-Spanne:

$14.40

$31.66

Celldex Therapeutics Inc Stock (CLDX) Company Profile

Firmenname

Celldex Therapeutics Inc

Sektor

Healthcare (1141)

Branche

Biotechnology (637)

Telefon

908-200-7500

Adresse

53 FRONTAGE ROAD, HAMPTON

Mitarbeiter

186

Twitter

@search?q=celldex

Nächster Verdiensttermin

2024-11-04

Neueste SEC-Einreichungen

CLDX's Discussions on Twitter

Vergleichen Sie CLDX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CLDX Celldex Therapeutics Inc	26.77	1.83B	5.79M	-199.61M	-188.48M	-3.01
VRTX Vertex Pharmaceuticals Inc	407.79	106.37B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	460.46	59.90B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	564.63	60.40B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	796.92	49.56B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	320.10	36.88B	4.56B	-176.77M	225.30M	-1.7177

Celldex Therapeutics Inc Stock (CLDX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-04-28	Eingeleitet	Canaccord Genuity	Buy
2025-03-20	Eingeleitet	Morgan Stanley	Overweight
2025-02-13	Eingeleitet	UBS	Buy
2024-10-07	Eingeleitet	Citigroup	Buy
2024-09-30	Eingeleitet	Goldman	Neutral
2024-09-27	Herabstufung	Wolfe Research	Outperform → Peer Perform
2024-06-18	Eingeleitet	Stifel	Buy
2024-06-11	Eingeleitet	Wolfe Research	Outperform
2023-12-20	Eingeleitet	TD Cowen	Outperform
2023-11-10	Hochstufung	Wells Fargo	Underweight → Equal Weight
2023-08-22	Eingeleitet	Wells Fargo	Underweight
2021-09-17	Eingeleitet	Jefferies	Buy
2021-09-10	Eingeleitet	SVB Leerink	Outperform
2021-07-22	Eingeleitet	Guggenheim	Buy
2020-02-21	Eingeleitet	Cantor Fitzgerald	Overweight
2017-08-01	Fortgesetzt	H.C. Wainwright	Buy
2016-11-07	Eingeleitet	Aegis Capital	Buy
2016-03-08	Herabstufung	Jefferies	Buy → Hold
2016-03-07	Herabstufung	Guggenheim	Buy → Neutral
2016-03-07	Herabstufung	Leerink Partners	Outperform → Mkt Perform
2016-03-07	Herabstufung	Wedbush	Outperform → Neutral
2016-03-01	Eingeleitet	H.C. Wainwright	Buy
2015-08-11	Bestätigt	Brean Capital	Buy
2015-08-11	Bestätigt	Oppenheimer	Outperform
2015-08-11	Bestätigt	ROTH Capital	Buy
2015-06-02	Bestätigt	WBB Securities	Strong Buy
2014-11-17	Bestätigt	ROTH Capital	Buy
2014-03-04	Bestätigt	Oppenheimer	Outperform
2013-07-08	Bestätigt	Cantor Fitzgerald	Buy
2013-03-08	Bestätigt	Cantor Fitzgerald	Buy
2013-02-26	Bestätigt	Oppenheimer	Outperform
2013-01-10	Bestätigt	Cantor Fitzgerald	Buy
2012-10-02	Bestätigt	Oppenheimer	Outperform
2012-09-14	Bestätigt	Cantor Fitzgerald	Buy

Alle ansehen

Celldex Therapeutics Inc Aktie (CLDX) Neueste Nachrichten

Oct 10, 2025

How interest rate cuts could boost Celldex Therapeutics Inc. stockPortfolio Value Report & Daily Stock Momentum Reports - newser.com

Oct 10, 2025

Oct 09, 2025

Celldex Therapeutics (NASDAQ:CLDX) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat

Oct 09, 2025

Celldex Bets Big On Its Allergy Pipeline Breakthroughs - Finimize

Oct 09, 2025

Analyzing Celldex Therapeutics Inc. with risk reward ratio charts2025 Market Outlook & Weekly High Conviction Ideas - newser.com

Oct 09, 2025

Is Celldex Therapeutics Inc. still worth holding after the dip2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - newser.com

Oct 09, 2025

When is the best time to exit Celldex Therapeutics Inc.2025 Fundamental Recap & Weekly High Momentum Picks - newser.com

Oct 09, 2025

Best data tools to analyze Celldex Therapeutics Inc. stockJuly 2025 Setups & Fast Entry Momentum Trade Alerts - newser.com

Oct 09, 2025

Will Celldex Therapeutics Inc. rebound enough to break evenMarket Risk Report & Reliable Intraday Trade Alerts - newser.com

Oct 09, 2025

Oct 08, 2025

Celldex Therapeutics Experiences Evaluation Revision Amidst Market Dynamics and Performance Fluctuations - Markets Mojo

Oct 08, 2025

Oct 07, 2025

Celldex Therapeutics (NASDAQ:CLDX) Share Price Crosses Above 200 Day Moving AverageHere's Why - MarketBeat

Oct 07, 2025

Oct 03, 2025

How moving averages guide Celldex Therapeutics Inc. trading2025 Institutional Moves & Consistent Growth Stock Picks - newser.com

Oct 03, 2025

Oct 02, 2025

Is Celldex Therapeutics Inc. reversing from oversold territoryWeekly Trend Summary & Community Consensus Stock Picks - newser.com

Oct 02, 2025

Sep 29, 2025

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Sep 29, 2025

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Sep 29, 2025

Sep 27, 2025

Celldex Therapeutics (NASDAQ:CLDX) Stock Price Crosses Above 200-Day Moving Average – Here’s What Happened - Defense World

Sep 27, 2025

Analysis: Positioning to Benefit within Applied Materials, MRC Global, Meritor, Celldex Therapeutics, Quaker Chemical, and Cu... - ADVFN

Sep 27, 2025

Celldex Therapeutics (NASDAQ:CLDX) Stock Price Crosses Above 200-Day Moving AverageHere's What Happened - MarketBeat

Sep 27, 2025

Sep 25, 2025

One Celldex Therapeutics Insider Raised Stake By 40% In Previous Year - 富途牛牛

Sep 25, 2025

Sep 23, 2025

Sovran Advisors LLC Purchases New Shares in Celldex Therapeutics, Inc. $CLDX - MarketBeat

Sep 23, 2025

Sep 22, 2025

Mirador Capital Partners LP Raises Holdings in Celldex Therapeutics, Inc. $CLDX - MarketBeat

Sep 22, 2025

Sep 21, 2025

Canaccord Genuity Group Reaffirms Buy Rating for Celldex Therapeutics (NASDAQ:CLDX) - MarketBeat

Sep 21, 2025

Technical signs of recovery in Celldex Therapeutics Inc.July 2025 Final Week & Real-Time Stock Price Movement Reports - newser.com

Sep 21, 2025

Why Celldex Therapeutics Inc. is moving todayWeekly Stock Analysis & Daily Stock Trend Reports - newser.com

Sep 21, 2025

Sep 19, 2025

How correlated is Celldex Therapeutics Inc to the S P500Market Growth Report & Entry and Exit Point Strategies - خودرو بانک

Sep 19, 2025

Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates - MSN

Sep 19, 2025

Key resistance and support levels for Celldex Therapeutics Inc.2025 AllTime Highs & Consistent Return Investment Signals - newser.com

Sep 19, 2025

Shorts Report: Will Celldex Therapeutics Inc benefit from geopolitical trendsTrade Risk Assessment & Weekly Setup with High ROI Potential - khodrobank.com

Sep 19, 2025